Copyright
©The Author(s) 2003.
World J Gastroenterol. Oct 15, 2003; 9(10): 2194-2197
Published online Oct 15, 2003. doi: 10.3748/wjg.v9.i10.2194
Published online Oct 15, 2003. doi: 10.3748/wjg.v9.i10.2194
Table 1 General clinical data
| Clinical parameters | Group A (n = 78) | Group B (n = 176) |
| Age (yr) | 51.72 (36-71) | 49.66 (14-74) |
| Male | 69 (88.64%) | 147 (83.52%) |
| HbsAg (+) | 67 (85.89%) | 151 (85.79%) |
| Child-Push grade | ||
| Grade A | 41 (52.54%)a | 124 (70.45%) |
| Grade B | 28 (35.90%)a | 38 (21.59%) |
| Grade C | 9 (11.53%) | 14 (8.0%) |
| Total resection rate | 47.92% (254/530)a | 33.21% (176/530) |
| Procedure time (min) | 268 (150-325)a | 178 (128-356) |
| Blood exclusion time (min) | 25.4 (12-55)a | 14.2 (8-28) |
| Blood loss (mL) | 818 (250-2800) | 725 (180-2400) |
| Blood transfusion (mL) | 690 (0-2400) | 620 (0-2600) |
| Total hospital stay time (d) | 29.4 (12-35) | 19.8 (10-39) |
| Re-operation | 11 (14.10%) | 16 (9.09%) |
| Emergency operation | 5 (6.41%) | 9 (5.11%) |
| Local hepatectomy | 12 (15.38%)a | 48 (27.28%) |
| Minor hepatectomy | 21 (26.92%)a | 96 (54.55%) |
| Major hepatectomy | 45 (57.69%)a | 32 (18.19%) |
| Caudate lobe hepatectomy | 4 (5.13%)a | 0 (0) |
Table 2 Pathologic data
| Clinical parameters | Group A (n = 78) | Group B (n = 176) |
| The mass | ||
| Median diameter (cm) | 11.58 (6.2-24.6)a | 6.25 (1.8-12.7) |
| > or = 5 cm | 72 (92.30%)a | 118 (67.05%) |
| > or = 10 cm | 53 (67.95%)a | 28 (15.90%) |
| Close or invade vana cana | 23 (29.49%)a | 17 (9.65%) |
| Close or invade major | 21 (26.92%)a | 13 (7.39%) |
| hepatic vein | ||
| Close or invade major bile duct | 11 (14.10%)a | 8 (4.55%) |
| Close or invade major port vein | 32 (41.03%)a | 22 (12.5%) |
| TNM tumor stage | ||
| Stage 1 | 6 (7.69%)a | 49 (27.84%) |
| Stage 2 | 12 (15.38%)a | 71 (40.34%) |
| Stage 3 | 36 (46.15%)a | 32 (18.19%) |
| Stage 4a | 20 (25.64%)a | 22 (12.5%) |
| Stage 4b | 4 (5.13%)a | 2 (1.14%) |
| Cirrhosis | 59 (75.64%) | 120 (68.18%) |
| Multiple tumor | 8 (10.25%)a | 6 (3.41%) |
| Caudate lobe tumor | 4 (5.13%)a | 0 (0) |
| Tumor free resection margin | 74 (94.87%) | 173 (98.3%) |
| Tumor rupture during operation | 11 (14.10%)a | 13 (7.39%) |
Table 3 Postoperative complications
| Clinical parameters | Group A | Group B |
| Bleeding | 16 (20.51%) | 29 (16.48%) |
| Bile leakage | 6 (7.69%)a | 8 (4.55%) |
| Infection (including abscess) | 12 (15.38%) | 23 (13.68) |
| Pleural effusion | 31 (39.74%)a | 34 (19.32%) |
| Reoperation within 24 h | 3 (3.85%) | 6 (3.40%) |
| after operation | ||
| Ascites | 16 (20.51%)a | 20 (11.36%) |
| Jaundice | 6 (7.69%)a | 5 (2.84%) |
| Hepatic failure | 6 (7.69%)a | 5 (2.84%) |
| Total morbidity | 40 (51.28%)a | 45 (25.57%) |
| Perioperative mortality | 2 (2.56%) | 5 (2.84%) |
Table 4 Outcome after hepatic resection
| Clinical parameters | Group A | Group B | Group C |
| Median disease-free | 14.6 (8-25) | 16.3 (9-37) | - |
| survival (m) | |||
| Median survival (m) | 40.5 (28-52) | 57.6 (33-84) | 8.8 (5-31) |
| Cumulative survival rate | |||
| 1 year survival | 92.3%b | 95.5%b | 29.9% |
| 3 year survival | 51.3%ab | 69.6%b | 2.9% |
| 5 year survival | 34.6%ab | 48.0%b | 0 |
| Remote metastasis rate | 16.27%a | 23.9%b | 14.8% |
- Citation: Yin ZY, Wang XM, Yu RX, Zhang BM, Yu KK, Li N, Li JS. Total vascular exclusion technique for resection of hepatocellular carcinoma. World J Gastroenterol 2003; 9(10): 2194-2197
- URL: https://www.wjgnet.com/1007-9327/full/v9/i10/2194.htm
- DOI: https://dx.doi.org/10.3748/wjg.v9.i10.2194